304 related articles for article (PubMed ID: 11113217)
1. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease.
Wang JC; Kwon JM; Shah P; Morris JC; Goate A
Neurology; 2000 Dec; 55(11):1644-9. PubMed ID: 11113217
[TBL] [Abstract][Full Text] [Related]
2. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.
Helisalmi S; Hiltunen M; Valonen P; Mannermaa A; Koivisto AM; Lehtovirta M; Ryynänen M; Soininen H
J Neurol; 1999 Sep; 246(9):821-4. PubMed ID: 10525981
[TBL] [Abstract][Full Text] [Related]
3. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.
Lambert JC; Araria-Goumidi L; Myllykangas L; Ellis C; Wang JC; Bullido MJ; Harris JM; Artiga MJ; Hernandez D; Kwon JM; Frigard B; Petersen RC; Cumming AM; Pasquier F; Sastre I; Tienari PJ; Frank A; Sulkava R; Morris JC; St Clair D; Mann DM; Wavrant-DeVrièze F; Ezquerra-Trabalon M; Amouyel P; Hardy J; Haltia M; Valdivieso F; Goate AM; Pérez-Tur J; Lendon CL; Chartier-Harlin MC
Neurology; 2002 Jul; 59(1):59-66. PubMed ID: 12105308
[TBL] [Abstract][Full Text] [Related]
4. ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population.
Juhász A; Palotás A; Janka Z; Rimanóczy A; Palotás M; Bódi N; Boda K; Zana M; Vincze G; Kálmán J
Neurochem Res; 2005 May; 30(5):591-6. PubMed ID: 16176061
[TBL] [Abstract][Full Text] [Related]
5. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
[TBL] [Abstract][Full Text] [Related]
6. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.
Town T; Paris D; Fallin D; Duara R; Barker W; Gold M; Crawford F; Mullan M
Neurosci Lett; 1998 Aug; 252(2):95-8. PubMed ID: 9756330
[TBL] [Abstract][Full Text] [Related]
7. The --491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease.
Alvarez-Arcaya A; Combarros O; Llorca J; Sánchez-Guerra M; Berciano J; Fernández-Luna JL
Neurosci Lett; 2001 May; 304(3):204-8. PubMed ID: 11343837
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the apolipoprotein E (APOE) gene in gerontopsychiatric patients.
Zill P; Engel R; Hampel H; Behrens S; Bürger K; Padberg F; Stübner S; Möller HJ; Ackenheil M; Bondy B
Eur Arch Psychiatry Clin Neurosci; 2001; 251(1):24-8. PubMed ID: 11315514
[TBL] [Abstract][Full Text] [Related]
10. Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease.
Rebeck GW; Cheung BS; Growdon WB; Deng A; Akuthota P; Locascio J; Greenberg SM; Hyman BT
Neurosci Lett; 1999 Sep; 272(3):155-8. PubMed ID: 10505604
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of vascular factors in Alzheimer's disease.
Wakutani Y; Kowa H; Kusumi M; Yamagata K; Wada-Isoe K; Adachi Y; Takeshima T; Urakami K; Nakashima K
Ann N Y Acad Sci; 2002 Nov; 977():232-8. PubMed ID: 12480755
[TBL] [Abstract][Full Text] [Related]
12. [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].
Hernández-Charro B; Moreno S; Valiente A; Manubens JM; Villar MD; Ramos-Arroyo MA
Med Clin (Barc); 2004 Sep; 123(7):251-4. PubMed ID: 15482730
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
[TBL] [Abstract][Full Text] [Related]
14. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T; Zhou X; Jin W; Zheng F; Cao X
Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
[TBL] [Abstract][Full Text] [Related]
15. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.
Lambert JC; Berr C; Pasquier F; Delacourte A; Frigard B; Cottel D; Pérez-Tur J; Mouroux V; Mohr M; Cécyre D; Galasko D; Lendon C; Poirier J; Hardy J; Mann D; Amouyel P; Chartier-Harlin MC
Hum Mol Genet; 1998 Sep; 7(9):1511-6. PubMed ID: 9700208
[TBL] [Abstract][Full Text] [Related]
16. Haplogroup analysis of the risk associated with APOE promoter polymorphisms (-219T/G, -491A/T and -427T/C) in Colombian Alzheimer's disease patients.
Parra-Bonilla G; Arboleda G; Yunis J; Solano E; Pardo R; Arango G; Hedmont D; Arboleda H
Neurosci Lett; 2003 Oct; 349(3):159-62. PubMed ID: 12951193
[TBL] [Abstract][Full Text] [Related]
17. The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.
Limon-Sztencel A; Lipska-Ziętkiewicz BS; Chmara M; Wasag B; Bidzan L; Godlewska BR; Limon J
Alzheimers Res Ther; 2016 May; 8(1):19. PubMed ID: 27193889
[TBL] [Abstract][Full Text] [Related]
18. [The relation between alpha1-antichymotrypsin gene polymorphism and epsilon4 allele of apolipoprotein E gene in Alzheimer disease in Chinese].
Tang G; Jiang S; Gu N; Jin T; Lin S; Qian Y; Wang D; Zhang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Apr; 16(2):94-6. PubMed ID: 10194255
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of the apolipoprotein E gene regulatory region and of the LDL receptor gene in late-onset Alzheimer's disease in relation to the plasma lipidic pattern.
Scacchi R; Gambina G; Martini MC; Ruggeri M; Ferrari G; Silvestri M; Schiavon R; Corbo RM
Dement Geriatr Cogn Disord; 2001; 12(2):63-8. PubMed ID: 11173876
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease.
Wang PN; Liu HC; Liu TY; Chu A; Hong CJ; Lin KN; Chi CW
Dement Geriatr Cogn Disord; 2005; 19(2-3):120-5. PubMed ID: 15591802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
